Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Nakaraang pagsara
¥18.50
Sakop ng araw
¥18.29 - ¥18.62
Sakop ng taon
¥12.93 - ¥34.18
Market cap
20.42B CNY
Average na Volume
18.87M
P/E ratio
40.76
Dividend yield
2.07%
Primary exchange
SHE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 816.14M | 11.21% |
Gastos sa pagpapatakbo | 441.56M | 6.14% |
Net na kita | 185.76M | -0.46% |
Net profit margin | 22.76 | -10.50% |
Kita sa bawat share | 0.16 | -2.13% |
EBITDA | 348.52M | 22.34% |
Aktuwal na % ng binabayarang buwis | 6.09% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 310.71M | -70.41% |
Kabuuang asset | 14.52B | -1.41% |
Kabuuang sagutin | 4.81B | -6.59% |
Kabuuang equity | 9.71B | — |
Natitirang share | 1.12B | — |
Presyo para makapag-book | 2.13 | — |
Return on assets | 5.17% | — |
Return on capital | 6.38% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 185.76M | -0.46% |
Cash mula sa mga operasyon | 178.68M | -37.64% |
Cash mula sa pag-invest | -262.60M | -774.60% |
Cash mula sa financing | -42.46M | -25,008.80% |
Net change in cash | -126.53M | -149.37% |
Malayang cash flow | -1.95B | -214.48% |
Tungkol
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Itinatag
Set 8, 1992
Website
Mga Empleyado
1,902
